相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma
Beatrice M. Razzo et al.
CARCINOGENESIS (2020)
Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages
Jiatao Liu et al.
HEPATOLOGY (2019)
Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8+ T Cell Responses
Fanghui Zhang et al.
IMMUNITY (2019)
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer
Bo Gong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Effects of exosomes on pre-metastatic niche formation in tumors
Yaxin Guo et al.
MOLECULAR CANCER (2019)
PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model
Neta Rosenzweig et al.
NATURE COMMUNICATIONS (2019)
Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment (vol 8, 12905, 2018)
Shin La Shu et al.
SCIENTIFIC REPORTS (2019)
Development of Cancer Immunotherapy Targeting the PD-1 Pathway
Naomi Kamimura et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2019)
Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics
Yoojin Seo et al.
STEM CELLS INTERNATIONAL (2019)
Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a
Xin Li et al.
STEM CELLS INTERNATIONAL (2019)
Exosomes in cancer development, metastasis, and immunity
Lin Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells
Yuanyuan Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT
Marie-Nicole Theodoraki et al.
ONCOIMMUNOLOGY (2019)
Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity-From Case Report to Mouse Model Validation
Shin-Yi Liu et al.
CANCERS (2019)
Efficacy and safety of combination immunotherapy for malignant solid tumors: A systematic review and meta-analysis
Yuhan Wei et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
Alexander Lux et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Yuan Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CD8+ T cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and, combined with GM-CSF and IL-12, enhance the anti-renal cortical adenocarcinoma effect
Hao-Yu Xu et al.
ONCOLOGY REPORTS (2019)
Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles
Chiara Cianciaruso et al.
CELL REPORTS (2019)
Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9
Yungang Wang et al.
ADVANCED SCIENCE (2019)
HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape
Qiuju Han et al.
CELLS (2019)
Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma
Jing Ma et al.
FRONTIERS IN ONCOLOGY (2019)
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Dong Ha Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity
Huanbin Wang et al.
NATURE CHEMICAL BIOLOGY (2019)
Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes
Ling Li et al.
ONCOGENE (2019)
Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma
Kazuto Harada et al.
GASTRIC CANCER (2018)
Role of stem cell derived exosomes in tumor biology
Aman Sharma
INTERNATIONAL JOURNAL OF CANCER (2018)
New insights into the biological impacts of immune cell-derived exosomes within the tumor environment
Meng Shen et al.
CANCER LETTERS (2018)
Exosome-mediated regulation of tumor immunology
Naohiro Seo et al.
CANCER SCIENCE (2018)
Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
Yi Yang et al.
CELL RESEARCH (2018)
Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6
Danfeng Guo et al.
IMMUNOLOGY (2018)
Tumor exosomes block dendritic cells maturation to decrease the T cell immune response
Yongling Ning et al.
IMMUNOLOGY LETTERS (2018)
Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells
Naohiro Seo et al.
NATURE COMMUNICATIONS (2018)
Extracellular Vesicles as Markers and Mediators in Sepsis
Pierre Raeven et al.
THERANOSTICS (2018)
Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression
Furong Wang et al.
ONCOGENESIS (2018)
Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease
Margot Zoeller
FRONTIERS IN IMMUNOLOGY (2018)
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
Franz L. Ricklefs et al.
SCIENCE ADVANCES (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis
Yunchen Yang et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules
Zaira Boussadia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Yaxiong Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
Marie-Nicole Theodoraki et al.
CLINICAL CANCER RESEARCH (2018)
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
A. M. Menzies et al.
ANNALS OF ONCOLOGY (2017)
Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages
Liang Cheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Extracellular vesicles-mediated noncoding RNAs transfer in cancer
Pei Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models
Zhen Lu et al.
JOURNAL OF HEPATOLOGY (2017)
NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells
Alireza Shoae-Hassani et al.
JOURNAL OF IMMUNOTHERAPY (2017)
Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
Fengming Yang et al.
MOLECULAR CANCER (2017)
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
Canan Kasikara et al.
MOLECULAR CANCER RESEARCH (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway
Song-An Zhang et al.
TUMOR BIOLOGY (2017)
Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
Liya Zhu et al.
THERANOSTICS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression
Fang Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Promote Tumor Growth Through Hedgehog Signaling Pathway
Jin Qi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model
Fang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Migrating into the Tumor: a Roadmap for T Cells
Lieke L. van der Woude et al.
TRENDS IN CANCER (2017)
Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer
Sonja Ludwig et al.
CLINICAL CANCER RESEARCH (2017)
Tumor-derived exosomes modulate PD-L1 expression in monocytes
Franziska Haderk et al.
SCIENCE IMMUNOLOGY (2017)
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)
Naoya Yamazaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf et al.
BREAST CARE (2016)
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Mercedes Tkach et al.
CELL (2016)
Tumor-Derived Exosomes Elicit Tumor Suppression in Murine Hepatocellular Carcinoma Models and Humans In Vitro
Quan Rao et al.
HEPATOLOGY (2016)
Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment
Stefani Spranger
INTERNATIONAL IMMUNOLOGY (2016)
The biology and function of exosomes in cancer
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2016)
The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation
Kankana Bardhan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
Bridgette A. Kanz et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells
Abu Musa Md Talimur Reza et al.
SCIENTIFIC REPORTS (2016)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Exosomes and their roles in immune regulation and cancer
David W. Greening et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2015)
Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
Liufu Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities
Ye Yao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Natural CD8(+)25(+) regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma
Yufeng Xie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
Li Shi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway
Zhijian Cai et al.
JOURNAL OF IMMUNOLOGY (2012)
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
Ping Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation
Nikolaos Patsoukis et al.
SCIENCE SIGNALING (2012)
CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity
Haifeng Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma
Ning Bu et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy
Pyong-Gon Moon et al.
PROTEOMICS (2011)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses
Ingrid S. Zeelenberg et al.
CANCER RESEARCH (2008)
Human tumor nanoparticles induce apoptosis of pancreatic cancer cells
Elodie Ristorcelli et al.
FASEB JOURNAL (2008)
MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and fas Ligand/Fas-Dependent manner
Seon Hee Kim et al.
JOURNAL OF IMMUNOLOGY (2007)
Malignant effusions and immunogenic tumour-derived exosomes
F Andre et al.
LANCET (2002)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
分享论文
